XML 62 R46.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2020
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Estimated Fair Value of Stock Options The fair value of each stock option granted in 2020, 2019 and 2018, was estimated on the date of grant using the following weighted-average assumptions.
    
Year Ended December 31,
 
    
2020
   
2019
   
2018
 
Dividend yield
     4.0     2.4     2.4
Volatility
     27.1     23.3     25.4
Risk-free interest rate
     0.4     2.5     2.9
Expected life
         5.3 years           5.4 years           5.4 years  
Weighted average grant date fair value
   $ 2.56     $ 4.35     $ 5.08  
Option Activity under Company's Stock Option Plans
The following table presents option activity under the Company’s stock option plans as of and for the year ended December 31, 2020.
 
    
Number of
Stock Options
Outstanding
   
Weighted
Average
Exercise Price
   
Weighted
Average
Remaining
Contractual
Term
   
Aggregate
Intrinsic Value
 
    
(In thousands)
         
(In years)
   
(In thousands)
 
Outstanding at January 1, 2020
     359     $ 17.99                  
Granted
     217       18.12                  
Exercised
     (20     11.64                  
Forfeited or expired
     (128     20.59                  
    
 
 
   
 
 
                 
Outstanding at December 31, 2020
     428     $ 17.57       4.65     $ 1,021  
    
 
 
   
 
 
                 
Vested or expected to vest at December 31, 2020
     428     $ 17.57       4.65     $ 1,021  
Exercisable at December 31, 2020
     175     $ 16.10       4.03     $ 685  
Summary of Status of Company's Non-Vested Restricted Shares
The table below summarizes activity related to the Company’s
non-vested
RSAs and RSUs for the year ended December 31, 2020.
 
    
Shares
   
Weighted
Average Fair
Value
 
 
  
(In thousands)
 
 
 
 
Nonvested at January 1, 2020
     441     $ 21.25  
Granted
     358       18.20  
Vested
     (302     20.70  
Forfeited
     (6     21.34  
    
 
 
   
 
 
 
Nonvested at December 31, 2020
     491     $ 19.36